AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30919909 — intervention group
Group type: EXPERIMENTAL
Intervention: PCI with everolimus-eluting stents
Number of subjects: 1858
Study 30919909 — intervention group
Group type: COMPARATOR
Intervention: CABG
Number of subjects: 1858
Study 30919909 — intervention group
Group type: EXPERIMENTAL
Intervention: Periprocedural myocardial infarction (PMI)
Number of subjects: 1858
Study 30919909 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak post-procedure CK-MB ≥10× URL
Number of subjects: 1858
Study 27865639 — intervention group
Group type: COMPARATOR
Intervention: Drug-eluting stent (DES)
Number of subjects: 4659
Study 27865639 — intervention group
Group type: COMPARATOR
Intervention: Femoropopliteal bypass surgery (BPS)
Number of subjects: 4659
Study 27865639 — intervention group
Group type: COMPARATOR
Intervention: Covered stent (CS)
Number of subjects: 4659
Study 27865639 — intervention group
Group type: COMPARATOR
Intervention: Nitinol stent (NS)
Number of subjects: 4659
Study 27865639 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of Nitinol stent (NS) with cryoplasty (CR) and drug-coated balloon
Number of subjects: 4659
Study 27865639 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-coated balloon
Number of subjects: 4659
Study 27865639 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty (BA)
Number of subjects: 4659
Study 27865639 — intervention group
Group type: COMPARATOR
Intervention: Cryoplasty (CR)
Number of subjects: 4659
Study 25986492 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based transesophageal echocardiography teaching via the Heartworks simulator (n = 12)
Number of subjects: 25
Study 25986492 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving transesophageal echocardiography teaching during elective cardiac surgery (n = 13)
Number of subjects: 25
Study 23504694 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclatasvir (60 mg once daily) and asunaprevir (600 mg twice daily) for 24 weeks (Group A)
Number of subjects: 21
Study 23504694 — intervention group
Group type: COMPARATOR
Intervention: Daclatasvir (60 mg once daily) and asunaprevir (600 mg twice daily) with peginterferon alfa-2a and ribavirin for 24 weeks (Group B)
Number of subjects: 21
Study 21674385 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-independent functional training (TIFT)
Number of subjects: 37
Study 21674385 — intervention group
Group type: COMPARATOR
Intervention: Time-dependent training (TD)
Number of subjects: 37
Study 21674385 — intervention group
Group type: COMPARATOR
Intervention: Visual demonstration
Number of subjects: 37
Study 19622986 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced patients with vaginal deliveries
Number of subjects: 1274
Study 19622986 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiparity
Number of subjects: 1274
Study 19622986 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal BMI less than 30
Number of subjects: 1274
Study 19622986 — intervention group
Group type: EXPERIMENTAL
Intervention: Height greater than 5'5"
Number of subjects: 1274
Study 19622986 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline modified Bishop score of 4
Number of subjects: 1274
Study 19622986 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth weight below 4,000 g
Number of subjects: 1274
Study 19622986 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal age younger than 35 years
Number of subjects: 1274
Study 19622986 — intervention group
Group type: EXPERIMENTAL
Intervention: Hispanic race
Number of subjects: 1274
Study 19622986 — intervention group
Group type: EXPERIMENTAL
Intervention: African-American race
Number of subjects: 1274
Study 16681537 — intervention group
Group type: EXPERIMENTAL
Intervention: Coblation tonsillectomy
Number of subjects: 20
Study 16681537 — intervention group
Group type: COMPARATOR
Intervention: Dissection tonsillectomy
Number of subjects: 20
Study 12508046 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular two-implant retained overdentures (IOD)
Number of subjects: 60
Study 12508046 — intervention group
Group type: COMPARATOR
Intervention: Conventional complete dentures (CD)
Number of subjects: 60
Study 10822744 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based prevention program from the Alcohol Misuse Prevention Study (AMPS)
Number of subjects: 371
Study 8857075 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal administration of budesonide (2 mg in 100 ml fluid)
Number of subjects: 15
Study 8857075 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of budesonide (2 mg in gelatine capsule)
Number of subjects: 15
Study 1517614 — intervention group
Group type: EXPERIMENTAL
Intervention: fenfluramine
Number of subjects: 30
Study 1517614 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 6712030 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine heparin
Number of subjects: 86
Study 30954378 — intervention group
Group type: EXPERIMENTAL
Intervention: Delefilcon A
Number of subjects: 64
Study 30954378 — intervention group
Group type: EXPERIMENTAL
Intervention: Somofilcon A
Number of subjects: 64
Study 29879048 — intervention group
Group type: COMPARATOR
Intervention: Control (false TAES followed by saline injection after 30 minutes)
Number of subjects: 172
Study 29879048 — intervention group
Group type: EXPERIMENTAL
Intervention: TAES (TAES followed by saline injection after 30 minutes)
Number of subjects: 172
Study 29879048 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil (false TAES followed by low‐dose sufentanil (0.1 μg/kg) injection after 30 minutes)
Number of subjects: 172
Study 29879048 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil plus TAES (TAES followed by low‐dose sufentanil injection after 30 minutes)
Number of subjects: 172
Study 27499187 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised nutrition (PN) advice
Number of subjects: 1480
Study 27499187 — intervention group
Group type: COMPARATOR
Intervention: Control, non-personalised dietary intervention
Number of subjects: 1480
Study 25027338 — intervention group
Group type: EXPERIMENTAL
Intervention: LigaSure® Vessel Sealing System (LVSS)
Number of subjects: 54
Study 25027338 — intervention group
Group type: COMPARATOR
Intervention: Conventional Clamp‐Tie (CT)
Number of subjects: 54
Study 22182405 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 30
Study 22182405 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 30
Study 19467896 — intervention group
Group type: EXPERIMENTAL
Intervention: DTPa‐HBV/Hib
Number of subjects: 360
Study 19467896 — intervention group
Group type: COMPARATOR
Intervention: DTPa‐HBV
Number of subjects: 360
Study 19467896 — intervention group
Group type: EXPERIMENTAL
Intervention: DTPa‐HBV/Hib booster
Number of subjects: 360
Study 19467896 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP administered to lower responders
Number of subjects: 360
Study 18162243 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentavalent rotavirus vaccine (PRV)
Number of subjects: 70000
Study 18162243 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70000
Study 16336071 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive family‐based behavioral treatment program
Number of subjects: 54
Study 16336071 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment incorporating reinforcing children for engaging in alternative behaviors to eating
Number of subjects: 54
Study 16336071 — intervention group
Group type: COMPARATOR
Intervention: Activities that compete with eating (within-subject design)
Number of subjects: 54
Study 12490092 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose group received a primary dose of 1000 units of the new vaccine.
Number of subjects: 104
Study 12490092 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose group received a primary dose of 500 units of the new vaccine.
Number of subjects: 104
Study 12490092 — intervention group
Group type: COMPARATOR
Intervention: Havrix group received a primary dose of 1440 enzyme-linked immunosorbent assay units of Havrix.
Number of subjects: 104
Study 12490092 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose group (1000 units) at month 6.
Number of subjects: 104
Study 12490092 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose group (1000 units) one month after booster dose.
Number of subjects: 104
Study 10401914 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium augmentation
Number of subjects: 41
Study 10401914 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 8583016 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessment focused on gingival bleeding (group I)
Number of subjects: 493
Study 8583016 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessment focused on plaque (group II)
Number of subjects: 493
Study 8583016 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 493
Study 2205290 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 micrograms ethinyl oestradiol daily by mouth for 10 days
Number of subjects: 36
Study 2205290 — intervention group
Group type: COMPARATOR
Intervention: Placebo daily by mouth for 10 days
Number of subjects: 36
Study 391094 — intervention group
Group type: EXPERIMENTAL
Intervention: N‐(3',4'‐dimethoxycinnamoyl) anthranilic acid (N‐5')
Number of subjects: 3
Study 391094 — intervention group
Group type: COMPARATOR
Intervention: Control group (N0)
Number of subjects: 3
Study 29712515 — intervention group
Group type: EXPERIMENTAL
Intervention: IV infusion of 30 IU of oxytocin started before uterine incision (Group I)
Number of subjects: 200
Study 29712515 — intervention group
Group type: COMPARATOR
Intervention: IV infusion of 30 IU of oxytocin started after clamping the umbilical cord (Group II)
Number of subjects: 200
Study 29712515 — intervention group
Group type: COMPARATOR
Intervention: Group II (after clamping the umbilical cord)
Number of subjects: 200
Study 29712515 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I (before uterine incision)
Number of subjects: 200
Study 27884081 — intervention group
Group type: EXPERIMENTAL
Intervention: Titratable mandibular advancement appliance (MAA)
Number of subjects: 12
Study 27884081 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-titratable mandibular advancement appliance (MAA)
Number of subjects: 12
Study 27884081 — intervention group
Group type: COMPARATOR
Intervention: Both types of MAAs
Number of subjects: 12
Study 24817063 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c
Number of subjects: 510
Study 24817063 — intervention group
Group type: EXPERIMENTAL
Intervention: ADDQoL
Number of subjects: 510
Study 24817063 — intervention group
Group type: EXPERIMENTAL
Intervention: Health status physical health summary score
Number of subjects: 510
Study 24817063 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c change
Number of subjects: 510
Study 23636616 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplements
Number of subjects: 35
Study 23636616 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (CG)
Number of subjects: 35
Study 23636616 — intervention group
Group type: COMPARATOR
Intervention: Asthmatic children (AG) without supplements
Number of subjects: 35
Study 21510853 — intervention group
Group type: COMPARATOR
Intervention: Background stroke care (limited, no thrombolytic therapy)
Number of subjects: 19435
Study 19002467 — intervention group
Group type: EXPERIMENTAL
Intervention: Iso-osmolar contrast medium (IOCM, iodixanol)
Number of subjects: 301
Study 19002467 — intervention group
Group type: COMPARATOR
Intervention: Low-osmolar contrast media (LOCM, iopamidol and iomeprol)
Number of subjects: 301
Study 17360872 — intervention group
Group type: EXPERIMENTAL
Intervention: malaria vaccine regimen FP9 ME‐TRAP/MVA ME‐TRAP
Number of subjects: 102
Study 17360872 — intervention group
Group type: EXPERIMENTAL
Intervention: sulfadoxine‐pyrimethamine (SP)
Number of subjects: 102
Study 17360872 — intervention group
Group type: COMPARATOR
Intervention: rabies vaccine
Number of subjects: 102
Study 15030837 — intervention group
Group type: EXPERIMENTAL
Intervention: Honan intraocular pressure reducer (HIPR)
Number of subjects: 45
Study 15030837 — intervention group
Group type: COMPARATOR
Intervention: No compression
Number of subjects: 45
Study 11157317 — intervention group
Group type: EXPERIMENTAL
Intervention: High isoflavone diet (132 +/- 22 mg isoflavones/d)
Number of subjects: 18
Study 11157317 — intervention group
Group type: EXPERIMENTAL
Intervention: Low isoflavone diet (65 +/- 11 mg isoflavones/d)
Number of subjects: 18
Study 11157317 — intervention group
Group type: COMPARATOR
Intervention: Control diet (7.1 +/- 1.1 mg isoflavones/d)
Number of subjects: 18
Study 9559237 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban Integrated Service Agency (ISA)
Number of subjects: 0
Study 9559237 — intervention group
Group type: EXPERIMENTAL
Intervention: Rural Integrated Service Agency (ISA)
Number of subjects: 0
Study 7840430 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro anion-exchange chromatography/enzyme immunoassay
Number of subjects: 245
Study 7840430 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial kit with ready-to-use microcolumns and radioimmunoassay
Number of subjects: 245
Study 7840430 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (daily alcohol intake < 40 g)
Number of subjects: 245
Study 7840430 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic ethylic subjects
Number of subjects: 245
Study 7840430 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients suffering from non-alcoholic liver diseases
Number of subjects: 245
Study 7840430 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme and radioimmunoassays
Number of subjects: 245
Study 2628537 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline
Number of subjects: 0
Study 2628537 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline 0.01 mg/kg
Number of subjects: 0
Study 2628537 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol 0.007 mg/kg
Number of subjects: 0
Study 1018117 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigilance orientation
Number of subjects: 108
Study 1018117 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance orientation
Number of subjects: 108
Study 1018117 — intervention group
Group type: EXPERIMENTAL
Intervention: No orientation
Number of subjects: 108
Study 1018117 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal uncertainty (knowing vs. not knowing when shock would occur)
Number of subjects: 108
Study 1018117 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticipation time (1, 3, or 12 minutes)
Number of subjects: 108
Study 31823057 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Pain Inventory (BPI) intervention group
Number of subjects: 264
Study 31823057 — intervention group
Group type: EXPERIMENTAL
Intervention: Edmonton Symptom Assessment Scale (ESAS) intervention group
Number of subjects: 264
Study 31823057 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular use of paracetamol, anti-neuropathic pain drugs, and opioids in the intervention group
Number of subjects: 264
Study 31823057 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 264
Study 30205020 — intervention group
Group type: EXPERIMENTAL
Intervention: Implants placed in group O (osteoporosis)
Number of subjects: 48
Study 30205020 — intervention group
Group type: COMPARATOR
Intervention: Implants placed in group C (control)
Number of subjects: 48
Study 28039545 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical debridement (MD) with enamel matrix derivative (EMD)
Number of subjects: 46
Study 28039545 — intervention group
Group type: COMPARATOR
Intervention: Mechanical debridement (MD) alone
Number of subjects: 46
Study 25738212 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium plus Vitamin D3 (50,000 IU/wk)
Number of subjects: 118
Study 25738212 — intervention group
Group type: COMPARATOR
Intervention: Calcium placebo plus Vitamin D3 placebo
Number of subjects: 118
Study 25738212 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium (1000 mg/d) plus Vitamin D3 placebo
Number of subjects: 118
Study 25738212 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D3 placebo plus Calcium placebo
Number of subjects: 118
Study 23932192 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (PRT) in Early Exercise (EE) group
Number of subjects: 41
Study 23932192 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (PRT) in Delayed Exercise (DE) group
Number of subjects: 41
Study 23932192 — intervention group
Group type: COMPARATOR
Intervention: Self‐chosen physical activity in Early Exercise (EE) group
Number of subjects: 41
Study 23932192 — intervention group
Group type: COMPARATOR
Intervention: Self‐chosen physical activity in Delayed Exercise (DE) group
Number of subjects: 41
Study 21872439 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 1019
Study 21872439 — intervention group
Group type: COMPARATOR
Intervention: Non-statin treatment (Control)
Number of subjects: 1019
Study 19570393 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin added into 'all in one' bags
Number of subjects: 20
Study 19570393 — intervention group
Group type: COMPARATOR
Intervention: Insulin added into syringes and transfused by infusion pump
Number of subjects: 20
Study 22381573 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral PS instrumented TLIF
Number of subjects: 80
Study 22381573 — intervention group
Group type: COMPARATOR
Intervention: Bilateral PS instrumented TLIF
Number of subjects: 80
Study 22381573 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Unilateral and Bilateral PS)
Number of subjects: 80
Study 15995106 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacitracin solution (group B)
Number of subjects: 400
Study 15995106 — intervention group
Group type: COMPARATOR
Intervention: Castile soap solution (group C)
Number of subjects: 400
Study 12821883 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat monounsaturated-fat-enriched diet (MUFA)
Number of subjects: 13
Study 12821883 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate low-fat diet (HCLF)
Number of subjects: 13
Study 10786507 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinaesthetic infant handling (KIH)
Number of subjects: 0
Study 10786507 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 8708198 — intervention group
Group type: EXPERIMENTAL
Intervention: CPN intervention
Number of subjects: 231
Study 8708198 — intervention group
Group type: COMPARATOR
Intervention: Continuing general practitioner care
Number of subjects: 231
Study 2247251 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-O2/N2O
Number of subjects: 62
Study 2247251 — intervention group
Group type: COMPARATOR
Intervention: Propofol-O2/air
Number of subjects: 62
Study 95337 — intervention group
Group type: EXPERIMENTAL
Intervention: Apekumarol
Number of subjects: 143
Study 95337 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 143
Study 11604622 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil solution for 5 minutes after excision
Number of subjects: 11
Study 11604622 — intervention group
Group type: COMPARATOR
Intervention: Phosphate-buffered saline for 5 minutes after excision
Number of subjects: 11
Study 30536413 — intervention group
Group type: EXPERIMENTAL
Intervention: Response-adaptive (RA) designs
Number of subjects: 0
Study 30536413 — intervention group
Group type: EXPERIMENTAL
Intervention: CARA designs
Number of subjects: 0
Study 29483080 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirukumab 100 mg every 2 weeks
Number of subjects: 559
Study 29483080 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirukumab 50 mg every 4 weeks
Number of subjects: 559
Study 29483080 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab 40 mg every 2 weeks
Number of subjects: 559
Study 29483080 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirukumab 100 mg
Number of subjects: 559
Study 29483080 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirukumab 50 mg
Number of subjects: 559
Study 29483080 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab
Number of subjects: 559
Study 27363733 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus helveticus Lafti L10 (2 × 10^10 CFU)
Number of subjects: 39
Study 27363733 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 25229956 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term educational intervention for parents (6 sessions on children's anxiety management)
Number of subjects: 49
Study 25229956 — intervention group
Group type: COMPARATOR
Intervention: Control group (follow-up only)
Number of subjects: 49
Study 23756581 — intervention group
Group type: EXPERIMENTAL
Intervention: Grana Padano cheese containing lysozyme (30 g)
Number of subjects: 25
Study 23756581 — intervention group
Group type: COMPARATOR
Intervention: TrentinGrana cheese (lysozyme-free, 30 g)
Number of subjects: 25
Study 19834732 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week combined cycle interval and muscle resistance training program
Number of subjects: 48
Study 19834732 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 48
Study 18450053 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 16307690 — intervention group
Group type: EXPERIMENTAL
Intervention: RMABE (Rhizophora mangle aqueous bark extract)
Number of subjects: 32
Study 16307690 — intervention group
Group type: EXPERIMENTAL
Intervention: RMABE
Number of subjects: 32
Study 12088916 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 microg iodide (group A)
Number of subjects: 86
Study 12088916 — intervention group
Group type: COMPARATOR
Intervention: 50 microg iodide (group B)
Number of subjects: 86
Study 12088916 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 86
Study 10460558 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine/silver sulphadiazine‐bonded catheters
Number of subjects: 228
Study 10460558 — intervention group
Group type: COMPARATOR
Intervention: Standard catheters
Number of subjects: 228
Study 7599662 — intervention group
Group type: EXPERIMENTAL
Intervention: Trisequens (17 beta‐estradiol and norethindrone acetate)
Number of subjects: 82
Study 7599662 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 7599662 — intervention group
Group type: EXPERIMENTAL
Intervention: Trisequens
Number of subjects: 82